Für den Arbeitskreis Prävention, Umwelt und komplementäre und alternative Medizin (AK PUK) von DGU und BDU.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamine E and beta carotene on the incidence of lung cancers and and other cancers in male smokers. N Engl J Med 300: 1029–1035
Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27:104–109
Brandt PA van den, Zeegers MP, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 12: 866–871
Byar D, Blackard C (1977) Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 10: 556–561
Capanna R, Donati D, Masetti C, Manfrini M, Panozzo A, Cadossi R, Campanacci M (1994) Effect of electromagnetic fields on patients undergoing massive bone graft following bone tumor resection. A double blind study. Clin Orthop 306: 213–221
Clark LC, Combs GF Jr, Turnball BW et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957–1963
Cohen JH, Kristal AR, Stanford JL (2000) Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 92: 61–68
Coker KH (1999) Meditation and prostate cancer: integrating a mind/body intervention with traditional therapies. Semin Urol Oncol 17: 111–118
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328: 246–252
Fair WR, Willet F, Whitmore WF (1999) Lecture: back to the future-the role of complementary medicine in urology. J Urol 162: 411–420
Fischer C, Schmitz-Dräger BJ, Altwein J (2002) Elektrophysikalische Verfahre. Energiefeldtherapie urologischer Erkrankungen. Verfahre. Energiefeldtherapie urologischer Erkrankungen. Urologe B 42: 316–319
Friedenreic, Klotz L, Trachtenberg J et al. C (1999) Prevalence and patterns of the use of complementary therapyes among prostate cancer patients: an epidemiological analysis. J Urol 161: 1521–1524
Oliveria SA, Lee IM (1997) Is exercise beneficial in the prevention of prostate cancer? Sports Med 23: 271–278
Ornish D, Fair W, Pettengil E et al. (2003) Can lifestyle changes reverse prostate cancer? J Urol 169(Suppl): 74
Papadopoulos I, Wand H (1989) Reducing the side effects of aggressive chemotherapy (cisplatin and epirubicin) with xenogenic peptides (factor AF2) in patients with hormone refractory metastatic prostate cancer. A prospective, randomized study. Onkologie 12(Suppl 3): 26–31
Pfeifer BL, Pirani JF, Hamann SR, Klippel KF (2000) PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int 85: 481–485
Quittan M, Schuhfried O, Wiesinger GF, Fialka-Moser V (2000) Klinische Wirksamkeiten der Magnetfeldtherapie — eine Literaturübersicht. Acta Med Austriaca 27: 61–68
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18: 2505–2514
Schmitz-Dräger BJ, Eichholzer M, Beiche B, Ebert T (2001) Nutrition and Prostate Cancer. Urol Int 67: 1–11
Sommer F, Klotz T, Schmitz-Dräger BJ (2004) Lifestyle issues and genitourinary tumors. World J Urol 21: 402–413
Studer UE, Jenzer S, Biedermann C, Chollet D, Kraft R, Toggenburg H von, Vonbank F (1995) Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. Eur Urol 28: 284–290
Taille A de la, Hayek OR, Buttyan R, Bagiella E, Burchardt M, Katz AE (1999) Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients. BJU Int 84: 845–850
Tsukayama H, Yamashita H, Amagai H, Tanno Y (2002) Randomised controlled trial comparing the effectiveness of electroacupuncture and TENS for low back pain: a preliminary study for a pragmatic trial. Acupunct Med 20: 175–180
Wannamethee SG, Shaper AG, Walker M (2001) Physical activity and risk of cancer in middle-aged men. Br J Cancer 85: 1311–1316
Zeegers MP, Kellen E, Buntinx F, Van Den Brandt PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 21: 392–401
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schmitz-Dräger, B.J., Lümmen, G., Klotz, T., Altwein, J.E. (2005). Komplementärmedizin in der urologischen Onkologie. In: Pharmakotherapie in der Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26450-7_9
Download citation
DOI: https://doi.org/10.1007/3-540-26450-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23449-4
Online ISBN: 978-3-540-26450-7
eBook Packages: Medicine (German Language)